Inflammatory Response Clinical Trial
— TRAIL PHYSIOOfficial title:
Per Effort Study of Inflammation During a 100 Miles
Verified date | August 2018 |
Source | Hôpital Necker-Enfants Malades |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
To study per and post effort variations of inflammatory biological markers during a 100 miles
Status | Not yet recruiting |
Enrollment | 20 |
Est. completion date | October 29, 2018 |
Est. primary completion date | October 18, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - adults (age>18years) - completion of an ultra endurance race (50 miles) during the 2 years before Exclusion Criteria: - female - age<18years |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Hôpital Necker-Enfants Malades |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Variation per and post effort of interleukin 1 plasma level | Plasma level of per and post effort of interleukin 1 will be measured | Change measures : departure, 25, 49, 72, 100, 126, 144, 164 kilometers (arrival) then at day 1, day 2 and day 7 after the completion of the race | |
Primary | Variation per and post effort of interleukin 6 plasma level | Plasma level of per and post effort of interleukin 6 will be measured | Change measures : departure, 25, 49, 72, 100, 126, 144, 164 kilometers (arrival) then at day 1, day 2 and day 7 after the completion of the race | |
Primary | Variation of per and post effort of protein C reactive | Plasma level of per and post effort of protein C reactive will be measured | Change measures : departure, 25, 49, 72, 100, 126, 144, 164 kilometers (arrival) then at day 1, day 2 and day 7 after the completion of the race | |
Primary | Variation per and post effort of interleukin Tumor Necrosis Factor alpha | Plasma level of per and post effort of tumor necrosis alpha will be measured | Change measures : departure, 25, 49, 72, 100, 126, 144, 164 kilometers (arrival) then at day 1, day 2 and day 7 after the completion of the race | |
Primary | Variation per and post effort of interleukin 4 plasma level | Plasma level of per and post effort of interleukin 4 will be measured | Change measures : departure, 25, 49, 72, 100, 126, 144, 164 kilometers (arrival) then at day 1, day 2 and day 7 after the completion of the race | |
Primary | Variation per and post effort of interleukin 10 plasma level | Plasma level of per and post effort of interleukin 10 will be measured | Change measures : departure, 25, 49, 72, 100, 126, 144, 164 kilometers (arrival) then at day 1, day 2 and day 7 after the completion of the race | |
Primary | Variation per and post effort of interleukin 13 plasma level | Plasma level of per and post effort of interleukin 13 will be measured | Change measures : departure, 25, 49, 72, 100, 126, 144, 164 kilometers (arrival) then at day 1, day 2 and day 7 after the completion of the race | |
Primary | Variation per and post effort of interleukin tumor growth factor beta plasma level | Plasma level of per and post effort of tumor growth factor beta | Change measures : departure, 25, 49, 72, 100, 126, 144, 164 kilometers (arrival) then at day 1, day 2 and day 7 after the completion of the race | |
Primary | Variation per and post effort of lipids plasma level | Plasma level of per and post effort of lipids | Change measures : departure, 25, 49, 72, 100, 126, 144, 164 kilometers (arrival) then at day 1, day 2 and day 7 after the completion of the race | |
Primary | Variation per and post effort of lipoproteins plasma level | Plasma level of per and post effort of lipoproteins | Change measures : departure, 25, 49, 72, 100, 126, 144, 164 kilometers (arrival) then at day 1, day 2 and day 7 after the completion of the race |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
Not yet recruiting |
NCT06434701 -
Severe COVID-19 Infection in Children Presenting to EDs in Israel and England
|
N/A | |
Enrolling by invitation |
NCT05020210 -
Effect of Early Treatment With Sivelestat Sodium in ARDS Patients
|
||
Completed |
NCT04084301 -
Impact of Cardiopulmonary Bypass Flow on Renal Oxygenation, Blood Flow and Tubular Injury
|
N/A | |
Completed |
NCT04597983 -
Effect of 8-week Intake of 2S-hesperidin on Performance, Body Composition and Biochemicals Markers in Amateur Cyclists
|
N/A | |
Not yet recruiting |
NCT06016023 -
Evaluation of Macrophage Inflammatory Protein-1α as a Periodontal Disease Biomarker
|
||
Not yet recruiting |
NCT05990933 -
Role of Adrenaline in in the Inflammatory Response in Diabetes
|
N/A | |
Not yet recruiting |
NCT04608643 -
Inflammatory Markers and Cbc Indices in Severely Malnourished Children
|
||
Recruiting |
NCT01934049 -
Postoperative Recovery in Elderly Patients Undergoing Hip Hemi-arthroplasty
|
Phase 4 | |
Recruiting |
NCT01417923 -
The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal Pain
|
Phase 4 | |
Terminated |
NCT01377441 -
Effect of Intravenous Ibuprofen on Inflammatory Responses in Patients Undergoing Surgery With General Anesthesia.
|
Phase 4 | |
Completed |
NCT01301079 -
Evaluation of the Effect of Ketamine on Remifentanil-induced Hyperalgesia
|
Phase 3 | |
Terminated |
NCT00578578 -
Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein Levels
|
Phase 4 | |
Recruiting |
NCT04611334 -
The Effects of HRV Biofeedback on Chronic Kidney Disease Patient.
|
N/A | |
Recruiting |
NCT03510702 -
SCREENING OF EPIGENETIC BIOMARKERS (miRNAs) IN THE GINGIVAL SULCUS
|
||
Completed |
NCT03445234 -
Blueberries, Bananas, Exercise Recovery
|
N/A | |
Not yet recruiting |
NCT06450704 -
Cerebral and Anti-inflammatory Response Through Exercise - Mechanisms In Depressive Disorders
|
N/A | |
Not yet recruiting |
NCT05754294 -
Electric Polarization of Red Blood Cells : A Cohort Study to Assess the Erythrocytes Membrane Integrity Through Charge Conservation, Following Cardiac Surgery.
|
||
Completed |
NCT04864600 -
CANDLE - A Study of Acute Health Effects of Exposure to Particles Generated by Candles
|
N/A | |
Not yet recruiting |
NCT04386525 -
Omega 3 and Ischemic Stroke; Fish Oil as an Option
|
Phase 4 |